Turning Point Therapeutics, Inc.

CIK 1595893 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Turning Point Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 29, 202215-12G0001140361-22-031281
Aug 22, 2022EFFECT9999999995-22-002458
Aug 17, 202240001209191-22-046283
Aug 17, 2022S-8 POS0001140361-22-029968
Aug 17, 202240001209191-22-046291
Aug 17, 20228-K0001140361-22-029961
Aug 17, 202240001209191-22-046285
Aug 17, 202240001209191-22-046258
Aug 17, 202225-NSE0001354457-22-000467
Aug 17, 2022S-8 POS0001140361-22-029969
Aug 17, 2022S-8 POS0001140361-22-029970
Aug 17, 202240001209191-22-046271
Aug 17, 202240001209191-22-046284
Aug 17, 202240001209191-22-046264
Aug 17, 202240001209191-22-046273
Aug 17, 2022POS AM0001140361-22-029967
Aug 17, 202240001209191-22-046286
Aug 17, 2022S-8 POS0001140361-22-029971
Aug 17, 202240001209191-22-046268
Aug 17, 202240001209191-22-046272
Aug 16, 2022SC TO-T/A0001140361-22-029751
Aug 16, 2022SC 14D9/A0001140361-22-029752
Aug 9, 2022SC TO-T/A0001140361-22-028803
Aug 9, 2022SC 14D9/A0001140361-22-028805
Aug 8, 202210-Q0000950170-22-015542